This study was performed To guage the prospective in the CPPs with tumor-targeting Houses to deliver a cytotoxic payload to HCC cells. We explored employing a CXCR4-focusing on peptide, T22, fused with cytotoxic peptide PE24, like a novel therapeutic technique for CXCR4+ HCC cells. T22 was preferred as the nanocarrier https://georgen529chl1.ssnblog.com/profile